(Q44327930)
Statements
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer (English)
S Czok
C Y Muller
S J Lee
T Rutledge
S Blank
B Pothuri
scientific article published on 31 July 2012
No description defined